Advancing RNA therapeutics depends on understanding two critical questions: Where do drug candidates go, and what do they do ...
STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration ...
Approach Mixes UV/VIS with Spectral Content Profiling for Yield and Quality Assessment Molecular genetic assays strongly rely on well-performed nucleic acid isolation as contamination with ...
The department of chemistry hosted their weekly seminar series, which featured the research of two Georgetown graduate students, Nadia Sarfraz and Jordan Tanen, both seeking their PhD, on Oct. 12.
Profile of breast cancer in patients with Li-Fraumeni syndrome: An institutional experience. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results